HIT Consultant
MARCH 19, 2023
John Showalter, MD, Chief Product Officer at Linus Health The FDA’s recent accelerated approval of Leqembi was welcome news across the Alzheimer’s community. It is expected to be more than six times the size of the public health campaign for COVID-19. billion marketing the medication.
Health Law Advisor
JANUARY 30, 2023
Food and Drug Administration (“FDA”) to withdraw approval of Mifepristone, an FDA-approved drug used to end pregnancies in the first trimester. [1] The lawsuit has sparked concern by both industry and the FDA. abortions, according to the Guttmacher Institute. [2] abortions, according to the Guttmacher Institute. [2]
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
SEPTEMBER 27, 2023
Keith Thompson, Chief Medical Officer of NuraLogix Those of us old enough to recall the 1960s TV series “Star Trek” were fascinated by Dr. McCoy when he would simply point a scanner at his patients and analyze their condition. Once cleared by the FDA, these medical devices will be Class 2 software as medical device technology.
The Health Law Firm
DECEMBER 7, 2020
Board Certified by The Florida Bar in Health Law. In a September 15, 2020 memorandum, the current Secretary of the US Department of Health and Human Services (HHS), Alex Azar, barred the 0Food and Drug Administration (FDA) and other federal health agencies under his authority from independently enacting any new federal regulations.
Healthcare IT Today
AUGUST 28, 2023
Stephen Sofoul, SVP, Data & Decision Science Services at MultiPlan A critical challenge lies in the shortage of experienced financial analysts or data analysts capable of effectively analyzing the wealth of information that the healthcare industry holds. However, with healthcare being ever-evolving our regulations are also ever evolving.
Hall Render
APRIL 26, 2024
NATIONAL 5 numbers on the rise of Stark law violations 3 takeaways on the new federal data privacy proposal after its first public showcase 80% of Change Healthcare restored after cyberattack Authentication failure blamed for Change Healthcare ransomware attack Biden administration issues new rule to protect privacy of those seeking reproductive health (..)
Verisys
DECEMBER 12, 2023
Compliance Updates: December 2023 Overlook: Federal Legislation DEA Licensure Compacts Other Legislation Board Updates Federal Legislation: The TREATS Act has been proposed which would amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment. This bill is currently in committee.
Expert insights. Personalized for you.
98 
Let's personalize your content